Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Geert Grooteplein 28, 6525 GA Nijmegen, The Netherlands.
J Control Release. 2010 Oct 15;147(2):171-9. doi: 10.1016/j.jconrel.2010.06.030. Epub 2010 Jul 8.
Cationic cell-penetrating peptides (CPP) are receiving increasing attention as molecular transporters of membrane-impermeable molecules. Import of cationic CPP occurs both via endocytosis and - at higher peptide concentrations - in an endocytosis-independent manner via localized regions of the plasma membrane. At present, this endocytosis-independent import of cationic CPP is not well understood, but has been shown to be sensitive to various pharmacological inhibitors, suggesting a role of an unidentified enzymatic activity. Here, we demonstrate that the direct translocation of cationic CPP depends on a CPP-induced translocation of acid sphingomyelinase (ASMase) to the outer leaflet of the plasma membrane and ceramide formation. The involvement of ASMase in uptake was confirmed by a pharmacological inhibition of ASMase by imipramine and a subsequent rescue of uptake through external addition of sphingomyelinase, and by using ASMase-deficient cells. We also found that the threshold for direct CPP translocation can be lowered through addition of sphingomyelinase and that sphingomyelinase enhances the translocation of R9 coupled to low-molecular weight cargos, but not high-molecular weight cargos. In conclusion, we show that a previously poorly understood mechanism of cationic CPP import depends on the ASMase-dependent formation of ceramide on the outer leaflet of the plasma membrane. To our knowledge, this is the first illustration that a class of delivery vectors operates through the induction of an enzymatic activity that changes the lipid composition of the plasma membrane.
阳离子细胞穿透肽(CPP)作为膜不可渗透分子的分子转运体越来越受到关注。阳离子 CPP 的导入通过内吞作用发生,并且 - 在较高的肽浓度下 - 通过质膜的局部区域以非内吞作用的方式发生。目前,这种非内吞作用的阳离子 CPP 导入机制尚未得到很好的理解,但已显示对各种药理学抑制剂敏感,表明存在未鉴定的酶活性的作用。在这里,我们证明阳离子 CPP 的直接易位依赖于 CPP 诱导的酸性鞘磷脂酶(ASMase)向质膜外叶的易位和神经酰胺的形成。ASMase 在摄取中的参与通过使用阿米替林抑制 ASMase 的药理学证实,随后通过外部添加鞘磷脂酶和使用 ASMase 缺陷细胞进行摄取挽救得到证实。我们还发现,通过添加鞘磷脂酶可以降低直接 CPP 易位的阈值,并且鞘磷脂酶增强与低分子量货物偶联的 R9 的易位,但不增强与高分子量货物偶联的 R9 的易位。总之,我们表明,阳离子 CPP 导入的先前理解甚少的机制依赖于质膜外叶上 ASMase 依赖性神经酰胺的形成。据我们所知,这是首次说明一类递送载体通过诱导改变质膜脂质组成的酶活性起作用。